Martin Heinrich
The Public Record
Martin Heinrich is a United States Senator from New Mexico, serving since January 3, 2013. A member of the Democratic Party, Heinrich previously represented New Mexico's 1st congressional district in the U.S. House of Representatives from January 6, 2009, to January 3, 2013. Throughout his political career, he has focused on issues such as renewable energy, healthcare, and economic development, advocating for policies that benefit New Mexico's diverse communities.
The accelerated drug approval process at FDA can often be a game-changer for patients with serious medical conditions.
the last thing our families need at this critical moment is for politicians to undermine its authority or shortchange its efforts.
The only meaningful industrial policy in the last 30 years has been the Inflation Reduction Act.
The decisions the FDA makes, whether approving a medical device or approving a new drug, must be guided by science and data, not by political pressure.
Opioid and fentanyl use is having dire impacts in communities across the country, including my home state where two-thirds of drug overdose deaths involve an Opioid.
This judge has replaced his political agenda for the data-driven process used by the FDA.
the last thing our families need at this critical moment is for politicians to undermine its authority or shortchange its efforts.
the determination about whether drugs are safe and effective needs to be left to the experts at FDA, not politicians and certainly not judges.
This sets an incredibly dangerous precedent in terms of both women's reproductive rights but also the FDA's review of drugs.
The accelerated drug approval process at FDA can often be a game-changer for patients with serious medical conditions.
This judge has replaced his political agenda for the data-driven process used by the FDA.





